Robert Tynebor
9Patents
2h-index
14Co-inventors
40Inventor score
Filing activity: Oct 14, 2003 → Nov 14, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8404856B2 | Non-nucleoside reverse transcriptase inhibitors | Chemistry; Metallurgy | 8 | Active |
| US7196082B2 | Ophthalmic compositions for treating ocular hypertension | Chemistry; Metallurgy | 7 | Expired |
| US7494983B2 | Ophthalmic compositions for treating ocular hypertension | Human Necessities | 2 | Expired |
| US7547720B2 | Ophthalmic compositions for treating ocular hypertension | Chemistry; Metallurgy | 2 | Active |
| US7528163B2 | Ophthalmic compositions for treating ocular hypertension | Chemistry; Metallurgy | 2 | Expired |
| US7410992B2 | Ophthalmic compositions for treating ocular hypertension | Chemistry; Metallurgy | 1 | Expired |
| US7879875B2 | P38 kinase inhibiting agents | Human Necessities | 0 | Active |
| US7482345B2 | P38 kinase inhibiting agents | Chemistry; Metallurgy | 0 | Active |
| US7807684B2 | HIV reverse transcriptase inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.